Drugs Control Media Services - Drugscontrol
WEBWelcome to DrugsControl Media Services, India's Independent Drug Regulatory Resource Portal, We Provides Information Of Regulatory & Online News.
DrugsControl Media Services
WEBNew Delhi, 31 July 2024: The Central drug regulator, the Central Drugs Standard Control Organisation (CDSCO) has decided to accept the preclinical toxicity data already generated and accepted by regulatory authorities of other countries for review of new drugs, subsequent new drugs (SNDs) and fixed dose combinations (FDCs), subject ...
DCGI frames guidelines to ensure product traceability
WEBSep 25, 2024 · New Delhi, 12 Aug 2024: The Drugs Controller General of India (DCGI), the country's top drug regulator, has framed standard operating procedure and guidelines to ensure product traceability throughout the supply chain, as the menace of fake and spurious medicines grows. View Details.
WEBThe National Task force (NTF) for COVID-19 constituted by Indian Council of Medical Research also reviewed the use of HCQ for prophylaxis of SARS-CoV-2 infection for high risk population based on the emerging evidence on its safety and efficacy. The NTF reviewed the data on in-vitro testing of HCQ for antiviral efficacy against SARS-CoV-2, safety profile of HCQ reported to the ...
Study Identifies Hundreds of Potential Targets for Cancer Drugs
WEBSep 15, 2024 · News Detail. Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024) Washington/ Beijing, 12 Sept 2024: Most targeted cancer drugs work by blocking proteins in or on cancer cells that help tumors grow. But the process of identifying promising proteins to target can be painstaking and often leads to false starts and dead ends.
Over 60% FDCs used for mental illnesses in India unapproved by …
WEBNew Delhi, 29 Aug 2024: Over 60 percent fixeddose combination (FDC) drugs consumed for mental health disorders in India are “unapproved” and lack therapeutic benefit, an analysis has found amid a major crackdown on FDC drugs by …
Central Govt bans 14 fixed-dose combinations, likely posing …
WEBNew Delhi, 3 June 2023: The Central Government on Friday banned 14 fixeddose combinations (FDCs) of medicines as they have been found to lack therapeutic justification and have been recommended to be banned by an expert panel.
Health ministry bans 156 FDCs with immediate effect
WEBNew Delhi, 22 Aug 2024: The Union ministry of health and family welfare (MoHFW) has banned 156 fixed dose combinations including common cold, fever, antibacterial and antifungal medicines with immediate effect, stating that they are irrational combinations and use of these drugs is likely to involve risk to human beings ...
CDSCO initiates move to control tapentadol & pregabalin sale …
WEBNew Delhi, 29 Nov 2023: Central Drugs Standard Control Organization (CDSCO) will form a panel to examine whether more regulatory restrictions should be brought in place to curb the misuse of tapentadol, an opioidbased painkiller, and pregabalin, a medication widely used for managing nerve pain, it is learnt.
A new kind of drug for approved for schizophrenia promises fewer …
WEB4 days ago · Washington, 28 Sept 2024: For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twiceaday pill to be marketed by Bristol Myers Squibb ...